Dactinomycin

Dactinomycin

3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-; hbf 386; Lyovac cosmegen; Meractinomycin; Oncostatin K; X 97; Actactinomycin A IV; Actinomycin 7; Actinomycin AIV; Actinomycindioic D acid, dilactone; Actinomycin C1; actinomycin cl; Actinomycin D; (-)-actinomycin d; actinomycin i; Actinomycin I1; Actinomycin IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycin X 1; actinomycin x i; actinomyein-theo-val-pro-sar-meval; ACTO-D; AD; Dilactone actinomycindioic D acid; Dilactone actinomycin D acid; C1; Cosmegen; Dactinomycin D; dactinomyein d; 2-amino-4,6-dimethyl-3-oxo-N,N'-bis[2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-di(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide; 2-amino-4,6-dimethyl-3-oxo-N,N'-bis[2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxooctadecahydrocyclopenta[i][1,4,7,13]oxatriazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide; 2-amino-4,6-dimethyl-3-oxo-N,N'-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-di(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide; ACTD

50-76-0